Neurobehavioral Development of Neonatal Mice Following Blockade of VIP During the Early Embryonic Period
Authors:
- Karin A HeninsKHKarin A Henins
- Pierre GressensPGPierre Gressens
- Illana GozesIGIllana Gozes
- Mati FridkinMFMati Fridkin
- Douglas E BrennemanDBDouglas E Brenneman
- Joanna M HillJHJoanna M Hill
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.Journal of Clinical Investigation, 1994
- The Effect of Early Maternal Maladaptation on Fetal GrowthJournal of Perinatal Medicine, 1994
- The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptideFEBS Letters, 1993
- Cloning and Functional Expression of a Human Neuroendocrine Vasoactive Intestinal Peptide ReceptorBiochemical and Biophysical Research Communications, 1993
- Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratPeptides, 1991
- Early Neurobehavioral Disorders in the Micrencephalic Offspring Induced by Prenatal Treatment with N-Methyl-N-Nitrosourea or Methylazoxymethanol in the Rat.Journal of Veterinary Medical Science, 1991
- Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogenJournal of Neuroscience Research, 1990
- Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.Journal of Cell Biology, 1987
- Methylazoxymethanol acetate: Effect of postnatal injection on brain amines and behaviorPharmacology Biochemistry and Behavior, 1978
- Correlations between prenatally‐induced alterations in CNS cell populations and postnatal functionTeratology, 1977